Mark Weiss

Mark Weiss is a highly experienced professional in the field of Chemistry and regulatory consulting, currently serving as President of Aporthaceutics International LLC since October 2020. In addition to this role, Mark Weiss has been an Expert Consultant at NDA Partners LLC since November 2017, specializing in CMC and regulatory documentation. Previous positions include Senior CMC Consultant at Pop Test, LLC, and The FDA Group, LLC, providing expertise in CMC-related submissions and regulatory review. Mark Weiss has extensive experience in writing and consulting on regulatory documentation, having collaborated with various clients and companies, including Pfizer and Sarepta Therapeutics. Mark Weiss holds an MS in Specialized Journalism from New York University, an MA in Chemistry from Binghamton University, and a Bachelor of Science in Chemistry from Clarkson University.